Feasibility of a Patient-Specific Bolus Using the Life-Casting Method for Radiation Therapy

Abstract

Radiation therapy for treating shallow tumors is challenging, necessitating the use of boluses. This study introduces the first application of the life-casting method to fabricate patient-specific bolus molds from gypsum sheets, comparing them with commercial boluses. Our developed boluses reduced the air gap between the skin and bolus by 77.62% compared to that of commercial boluses. In vivo dosimetry using the patient-specific bolus demonstrated better results compared to using a commercial bolus. When using the commercial bolus, the mean %Diff and max %Diff were 1.10 ± 0.61%, respectively, and 2.00% for three-dimensional conformal radiation therapy (3D-CRT) and 7.19 ± 1.90% and 10.14% for volumetric modulated arc therapy (VMAT), respectively. Contrastingly, our developed bolus demonstrated more accurate dose delivery with a mean %Diff and max %Diff of 0.82 ± 0.61% and 1.69% for 3D-CRT and 3.42 ± 1.01% and 5.03% for VMAT, respectively. Furthermore, the standard deviation between the measurements was more than 50% lower when using a patient-specific bolus than when using a commercial bolus. These results show that our bolus reduces air gaps, improves the accuracy of bolus positioning, and enhances the precision of dose delivery compared with the performance of commercial boluses. Therefore, the developed bolus is expected to be valuable in clinical applications.